Table 2.

Tumor cells PDL1 protein and mRNA expression relationship with clinicopathological features.

	Clinical Parameters	Protein Positive	Negative	P value	mRNA Positvie	Negative	P value
Age				0.568			0.803
	<50	8	91		27	10
	≥50	5	91		35	11
Tumor size				0.701			0.152
	≤2cm	5	74		22	7
	>2cm≤5cm	8	98		38	10
	>5cm	0	8		3	2
P53				0.777			1.000
	positive	7	86		28	10
	negative	6	95		34	11
Ki-67 index				0.130			0.025
	<20%	0	35		13	10
	≥20%	13	147		49	11
TILs amount				1.000			0.449
	<30%	10	137		55	16
	≥30%	3	42		7	4
TILs PDL1 expression				0.001			0.006
	Positive	10	51		37	5
	negative	3	131		25	16
Basallike subtype				0.737			0.033
	Yes	11	141		46	10
	No	2	41		16	11
Histological type				1.000			0.488
	Invasive carcinoma of non-specific subtype	12	165		54	17
	others	1	11		8	4
Grade				0.352			0.034
	Grade1 or 2	2	59		18	12
	Grade 3	11	123		44	9
Stage				0.832			0.906
	I	3	47		13	4
	II	8	97		37	12
	III	2	38		12	5
Lymphnode metastasis				0.117			0.803
	Yes	2	80		30	10
	No	9	97		28	11
Distant metastasis				0.538			1.000
	Yes	5	52		26	9
	No	8	123		36	12